Metformin and/or Clomiphene Do Not Adversely Affect Liver or Renal Function in Women with Polycystic Ovary Syndrome | Zendy

Mira Aubuchon | Zendy; Allen R. Kunselman | Zendy; William D. Schlaff | Zendy; Michael P. Diamond | Zendy; Christos Coutifaris | Zendy; Sandra Ann Carson | Zendy; Michael P. Steinkampf | Zendy; Bruce R. Carr | Zendy; Peter G. McGovern | Zendy; Nicholas A. Cataldo | Zendy; Gabriella G. Gosman | Zendy; John E. Nestler | Zendy; Evan R. Myers | Zendy; Richard S. Legro | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Metformin and/or Clomiphene Do Not Adversely Affect Liver or Renal Function in Women with Polycystic Ovary Syndrome

Author(s) -

Mira Aubuchon,

Allen R. Kunselman,

William D. Schlaff,

Michael P. Diamond,

Christos Coutifaris,

Sandra Ann Carson,

Michael P. Steinkampf,

Bruce R. Carr,

Peter G. McGovern,

Nicholas A. Cataldo,

Gabriella G. Gosman,

John E. Nestler,

Evan R. Myers,

Richard S. Legro

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-1093

Subject(s) - polycystic ovary , metformin , medicine , renal function , creatinine , liver function , blood urea nitrogen , endocrinology , aspartate transaminase , liver function tests , nonalcoholic fatty liver disease , alanine transaminase , gastroenterology , insulin resistance , urology , insulin , fatty liver , disease , biology , alkaline phosphatase , enzyme , biochemistry

Nonalcoholic fatty liver disease is common to insulin-resistant states such as polycystic ovary syndrome (PCOS). Metformin (MET) is often used to treat PCOS but information is limited as to its effects on liver function.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research